Colorectal Neoplasms: all 5,734 studies
Page 53 of 58. Open to participants first (1,481), then studies with results posted, then the rest; newest registration first within each.
- Use of Novel Tailored Reminders in Rural Primary CareCompletedNCT00593073Not applicable
- Temsirolimus (CCI-770, Torisel) Combined With Cetuximab in Cetuximab-Refractory Colorectal CancerCompletedNCT00593060Phase 1
- Yield and Safety of Colonoscopy in Patients Older Than 80 YearsCompletedNCT00590434
- Utility of PET In the Pre-Operative Assessment of Patients With Hepatic Colorectal MetastasesCompletedNCT00588549
- Unprepped CT ColonographyCompletedNCT00586053
- Colorectal Cancer Screening Intervention for Family Members of Colorectal Cancer PatientsCompletedNCT00582829
- Attitudes Towards Prophylactic Colectomy in Hereditary Non-polyposis Colorectal Cancer (HNPCC) PatientsCompletedNCT00582452
- Identification of New Colorectal Cancer GenesCompletedNCT00582335
- Pain in Cancer SurvivorsCompletedNCT00581724
- Tissue and Serum Collection From Colorectal Cancer PatientsCompletedNCT00579891
- A Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Patients With Previously Untreated Metastatic Colorectal Cancer.WithdrawnNCT00577109Phase 2
- Phase I Study of KRN330 Monoclonal Antibody in Patients With Colorectal CancerCompletedNCT00575562Phase 1
- Cetuximab and Bevacizumab as First-Line Therapy Followed By Combination Chemotherapy and Bevacizumab With or Without Cetuximab as Second-Line Therapy in Treating Patients With Stage IV Colorectal CancerWithdrawnNCT00571740Phase 2
- Phase II Trial of Combination Therapy With Irinotecan, S-1, and Bevacizumab (IRIS/Bev) in Patients With Unresectable or Recurrent Colorectal CancerCompletedNCT00569790Phase 2
- Phase II Trial of Combination Therapy With Bevacizumab and S-1 in Elderly Patients With Unresectable or Recurrent Colorectal Cancer (BASIC)CompletedNCT00569699Phase 2
- Phase II Trial of Combination Therapy With S-1, Irinotecan, and Bevacizumab (SIRB) in Patients With Unresectable or Recurrent Colorectal CancerCompletedNCT00569335Phase 2
- Aspirin for Dukes C and High Risk Dukes B Colorectal CancersActive, not recruitingNCT00565708Phase 3
- Studying a Quality of Life Questionnaire in Patients With Colorectal CancerCompletedNCT00564694
- Follow-Up Study of Patients Who Have Undergone Surgery for Stage I, Stage II, or Stage III Colorectal CancerStatus unknownNCT00560365
- Pyridoxine in Preventing Hand-Foot Syndrome in Patients Who Are Receiving Capecitabine for Advanced Colorectal Cancer or Breast CancerStatus unknownNCT00559858Phase 3
- Cetuximab and Combination Chemotherapy in Treating Patients With Advanced or Metastatic Colorectal CancerCompletedNCT00559741Phase 2
- Study of Biomarkers in Patients Undergoing Chemotherapy for Metastatic Colorectal CancerCompletedNCT00559676Phase 4
- Effectiveness Study of a Computer-Based Colorectal Cancer Screening Decision AidCompletedNCT00558233Not applicable
- Alpha-type-1 Dendritic Cell-based Vaccines in Patients With Metastatic Colorectal CancerCompletedNCT00558051Phase 1
- Cetuximab and Combination Chemotherapy as First-Line Therapy in Treating Patients With Colorectal Cancer That Has Spread to the Liver and/or LungCompletedNCT00557102Phase 2
- Cetuximab and Combination Chemotherapy as First-Line Therapy in Treating Patients With Metastatic Colorectal CancerCompletedNCT00556413Phase 2
- DNA Changes That Affect Vitamin D Metabolism in Patients With Colorectal Cancer Receiving Vitamin D SupplementsCompletedNCT00550563Not applicable
- The Active After Cancer Trial (AACT)Active, not recruitingNCT00548236Not applicable
- Bevacizumab in Treating Patients Who Have Undergone First-Line Therapy for Metastatic Colorectal CancerTerminatedNCT00544700Phase 3
- Leucovorin, Fluorouracil, Cetuximab, and Oxaliplatin in Treating Patients With Stage IV Colorectal Cancer and Liver Metastases That Cannot Be Removed by SurgeryCompletedNCT00544349Phase 2
- Bevacizumab and Combination Chemotherapy in Treating Patients With Metastatic Colorectal CancerStatus unknownNCT00544011Phase 2
- G-CSF in Preventing Neutropenia During First-Line Treatment With Chemotherapy and Bevacizumab in Patients With Metastatic Colorectal CancerCompletedNCT00541125Phase 2
- Radiation Therapy, Chemotherapy, and Cetuximab Followed by Surgery, Chemotherapy, and Cetuximab in Treating Patients With Locally Advanced or Metastatic Rectal Cancer That Can Be Removed by SurgeryTerminatedNCT00541112Phase 2
- Study of Pazopanib, Irinotecan and Cetuximab in Combination to Treat 2nd Line Metastatic Colorectal CancerCompletedNCT00540943Phase 1
- AZD2281 and Irinotecan in Treating Patients With Locally Advanced or Metastatic Colorectal CancerCompletedNCT00535353Phase 1
- Phase I Vandetanib Plus Capecitabine, Oxaliplatin and Bevacizumab for Metastatic Colorectal CancerCompletedNCT00532909Phase 1
- A Phase I/II Trial of TS-1 and Oxaliplatin in Patients With Advanced Colorectal CancerCompletedNCT00531245Phase 1/2
- Phase II Study to Evaluate Safety and Efficacy of Cetuximab in Combination With XELOX for 12 Weeks Followed by Maintenance Treatment With Cetuximab Plus Capecitabine as First-line Treatment in Elderly Patients With Metastatic Colorectal Cancer.TerminatedNCT00531115Phase 2
- Multimedia Intervention in Patients With Familial Adenomatous Polyposis (FAP)CompletedNCT00525655Not applicable
- Phase I/II Study of SOL for Untreated Metastatic Colorectal CancerStatus unknownNCT00524706Phase 1/2
- Phase I/Randomized Phase II Study of Second Line Therapy With Irinotecan + Cetuximab +/- RAD001 for Colorectal CancerCompletedNCT00522665Phase 1/2
- Phase II Efficacy Study of AZD6244 in Colorectal CancerCompletedNCT00514761Phase 2
- Phase 1 Study of OSI-930 in Cancer PatientsCompletedNCT00513851Phase 1
- Combination Chemotherapy and Monoclonal Antibody Therapy in Treating Patients With Advanced Colorectal Cancer With Liver Metastases or Lung Metastases That Are Potentially Removable by SurgeryStatus unknownNCT00513266Phase 2
- Trial of Antibiotic Prophylaxis in Elective Laparoscopic Colorectal Surgery: Oral and Systemic Versus Systemic AntibioticsCompletedNCT00508690Phase 3
- Registry for Women Who Are At Risk Or May Have Lynch SyndromeCompletedNCT00508573
- Metabolomics-Based Detection of Colorectal CancerCompletedNCT00507598
- Ambulatory Cancer Pain Management: A Feasibility StudyCompletedNCT00507351
- Study of Genetic Polymorphisms of Drug Transporters and Orphan Nuclear Receptors on Treatment Effects of IrinotecanStatus unknownNCT00507143Not applicable
- Phase II Study of Irinotecan,Oxaliplatin Plus TS-1 in Untreated Metastatic Colorectal CancerStatus unknownNCT00506571Phase 2
- A Phase I Study of S-1 Plus Irinotecan and Oxaliplatin in Advanced Gastrointestinal MalignancyStatus unknownNCT00506207Phase 1
- Study of Irinotecan & Capecitabine in Metastatic Colorectal CancerTerminatedNCT00506168Phase 2
- Pilot Study of the National Colorectal Cancer Roundtable Toolbox (NCCRT) to Increase Colorectal Cancer Screening RatesCompletedNCT00503737Not applicable
- Assessment of Symptom-Related Cytokines in Lung and Gastrointestinal (GI) Cancer PatientsCompletedNCT00502502
- FOLFOX Chemotherapy Regimen (5-FU, Leucovorin, Oxaliplatin) in Metastatic Colorectal CancerCompletedNCT00501410Phase 1
- Phase I FOLFOX CombinationCompletedNCT00499850Phase 1
- Fludeoxyglucose F 18-PET Imaging for Early Detection of Residual Disease in Patients Undergoing Radiofrequency Ablation of Liver Metastases From Colorectal CancerCompletedNCT00499395Not applicable
- A Phase II Study of CP-4055 as Second Line Therapy in Patients With Advanced Colorectal CancerCompletedNCT00498407Phase 2
- A Study of PRO95780 in Combination With Cetuximab and Irinotecan Chemotherapy or the FOLFIRI Regimen With Bevacizumab in Patients With Previously Treated Metastatic Colorectal Cancer (APM4187g)CompletedNCT00497497Phase 1
- Uracil and Tegafur/Leucovorin (UFT/LV) Versus UFT/LV+ Polysaccharide-K (PSK) for Stage IIIa/IIIb Colorectal CancerStatus unknownNCT00497107Phase 3
- Gemcitabine, Capecitabine, and Oxaliplatin as Second-Line Therapy in Treating Patients With Advanced Colorectal Cancer Previously Treated With IrinotecanStatus unknownNCT00496704Phase 1/2
- Trial of Patient Navigation-ActivationCompletedNCT00496678Phase 4
- Phase I Efficacy On Vascular Permeability In Patients With Advanced Colorectal CancerCompletedNCT00496509Phase 1
- Study of Nimotuzumab and Irinotecan in Metastatic Colorectal CancerTerminatedNCT00493857Phase 2
- Hepatic Arterial Infusion With Floxuridine and Dexamethasone Combined With Combination Chemotherapy in Treating Patients With Colorectal Cancer That Has Spread to the LiverActive, not recruitingNCT00492999Phase 2
- Retrospective Study Assessing Molecular Features Predicting Response to CetuximabCompletedNCT00491140
- Evaluation of Contrast-enhanced Ultrasound Imaging for the Early Estimate of Bevacizumab Effect on Colorectal Cancer Liver MetastasesCompletedNCT00489697Not applicable
- Laparoscopic Assisted Versus Open Resection for Colorectal CarcinomaCompletedNCT00485316Phase 3
- A Phase II Study of Bevacizumab, Irinotecan and Capecitabine in Patients With Previously Untreated Metastatic Colorectal CancerCompletedNCT00483834Phase 2
- Study of NGR-hTNF as Single Agent in Patients Affected by Colorectal Cancer (CRC)CompletedNCT00483080Phase 2
- Combination Chemotherapy With or Without Cetuximab Before and After Surgery in Treating Patients With Resectable Liver Metastases Caused By Colorectal CancerStatus unknownNCT00482222Phase 3
- Double-Blind Randomized Placebo-Controlled Trial on Clinical and Biological Effects of Oral Corticosteroids or Doxycyclin in Patients With Nasal PolyposisCompletedNCT00480298Phase 2
- Safety and Efficacy of Folfox4 + Weekly Cetuximab vs Folfox 4+Biweekly Cetuximab by Metastatic Colorectal CancerCompletedNCT00479752Phase 2
- A Study of Picoplatin in Colorectal CancerStatus unknownNCT00478946Phase 1/2
- A Phase 1 Study Investigating the Combination of RAD001, Cetuximab and Irinotecan as Second-line Therapy After FOLFOX (or XELOX) Plus Bevacizumab in Patients With Metastatic Colorectal CancerCompletedNCT00478634Phase 1
- Genetic Epidemiology Risk Assessment Program or Usual Care in Colorectal Cancer Screening for Healthy ParticipantsCompletedNCT00478309Not applicable
- Colorectal Cancer Screening Navigator Program for Low Income and Non-English Speaking PopulationsCompletedNCT00476970Not applicable
- Panitumumab in Combination With Irinotecan Chemotherapy as 2nd-line Therapy in Subjects With mCRCCompletedNCT00475293Phase 2
- Follow-Up Phone Calls After Colorectal SurgeryCompletedNCT00474097
- Preoperative Non-steroidal Anti-inflammatory Drugs(NSAID) to Colorectal Cancer PatientsCompletedNCT00473980Phase 4
- Life After Cancer: Behavioral Treatment Study to Improve Quality of LifeCompletedNCT00473941Not applicable
- Randomized Phase III Study of Folfiri+Avastin Versus Xeliri+Avastin as 1st Line Treatment of CRCCompletedNCT00469443Phase 3
- Post-Op Quality of Life After Colorectal SurgeryCompletedNCT00468455
- Evaluation of NiTi Shape Memory End-to-End Compression Anastomosis Ring (CAR) for Compression Anastomosis in Anterior ResectionStatus unknownNCT00468416Phase 2
- Genes That Affect Disease Outcome in Patients With Metastatic Colorectal CancerStatus unknownNCT00467129
- Comparison of Bowel Preparation in Virtual Colonoscopy (VC) - Patient ExperienceWithdrawnNCT00460837Phase 4
- Study of the Antitumor Activity of Capecitabine in Combination With Erlotinib in Patients With Metastatic Colorectal CancerTerminatedNCT00459901Phase 2
- Traditional Print Communication Methods, Simple Electronic Communication Methods, or Usual Care in Increasing How Often Older Women Undergo Colorectal Cancer ScreeningCompletedNCT00459030Not applicable
- Intraperitoneal Hyperthermic Perfusion With Oxaliplatin in Treating Patients With Stage IV Peritoneal Cancer Due to Appendix Cancer or Colorectal CancerCompletedNCT00458809Phase 1
- Surgery Plus Intraoperative Peritoneal Hyperthermic Chemotherapy (IPHC) to Treat Peritoneal CarcinomatosisStatus unknownNCT00454519Phase 2
- Cancer Prevention and Treatment Demonstration for Ethnic and Racial MinoritiesCompletedNCT00453661
- Arsenic Trioxide, Fluorouracil, and Leucovorin in Treating Patients With Stage IV Colorectal Cancer That Has Relapsed or Not Responded to TreatmentCompletedNCT00449137Phase 1
- Pre- and Postoperative Chemotherapy Including Bevacizumab in Potentially Curable Metastatic Colorectal CancerCompletedNCT00444041Phase 1/2
- Maintenance Treatment Versus Observation After Induction in Advanced Colorectal CarcinomaStatus unknownNCT00442637Phase 3
- Dissemination of Colorectal Cancer Screening to Primary Care PhysiciansCompletedNCT00441311Phase 4
- Cetuximab, Leucovorin, Oxaliplatin, and Fluorouracil With or Without Bevacizumab in Treating Patients With Resectable Liver Metastases From Colorectal CancerStatus unknownNCT00438737Phase 2
- Colonoscopy by Videocapsuls Versus Standard Colonoscopy. Intra-individual Comparison for the Subject With a Medium or High Risk of Colorectal Cancer.CompletedNCT00436514Not applicable
- Improving Followup of Abnormal Colon Cancer Screening TestsCompletedNCT00436137Not applicable
- ZD6474, Cetuximab, and Irinotecan in Patients With Metastatic Colorectal CancerCompletedNCT00436072Phase 1
- Computer Assisted Early Detection of Liver Metastases From fMRI MapsStatus unknownNCT00435097